NorthWest Biotherapeutics Inc (NWBO)

[TTsr]

Me thinks you are lying, again. Read below how EAMS works & consider DCVax was the FIRST PIM granted by UK.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763516/

“The early access to medicine scheme (EAMS) which was launched in April 2014 in the UK is a three step process. In the first step, companies can submit a phase I/II data to the Medicines and Healthcare products Regulatory Agency (MHRA) and apply for a promising innovative medicine (PIM) designation. Upon receipt of the positive PIM designation, in stage 2, the MHRA reviews the data. If the EAMS scientific opinion is positive, then in the third stage is the commissioning of the drug in the National Health Service. Fees are levied at each stage of the application and contrary to other countries such as the USA and France, the early access provided by the company through EAMS is free of cost.[16] Other countries where early access to medicines is provided free of cost include Austria, Germany, Greece, and Spain.”